US46124U1079 - ADR
Inventiva SA (NASDAQ:IVA) stock traded higher on Monday, with a strong session volume of 8.55 million compared to an average volume of 9.91k, according to data from Benzinga Pro. The company announced it has secured financing of immediately 94.1 million euros ($99.36 million) and up to 348 million euros ($379.55 million) to fund the completion of the Phase 3 NATiV3 MASH trial and preparation for the potential filing for marketing approval and commercialization of lanifibranor. The Transaction wa
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Inventiva (IVA) stock plummeted as it announced a delay in its Phase 3 trial for NASH candidate lanifibranor due to an adverse event. Read more here.
Biopharmaceutical firm Inventiva (IVA) Thursday announced a €35.7 million raise consisting of a capital increase and issuance of royalty certificates.The capital increase would be...
Inventiva (IVA) added ~25% Wednesday on positive data from a Phase 2 trial for its lead candidate lanifibranor targeted at nonalcoholic steatohepatitis. Read more here.
Plug Power (PLUG) stock is on the move Wednesday after the EV charging company announced a deal with Avina Clean Hydrogen.
Cineverse (CNVS) stock is falling on Wednesday after the company revealed the pricing of an $8 million public share offering.
Eastside Distilling (EAST) stock is taking a beating on Wednesday after the company revealed plans to trade debt for equity.
Inventiva (IVA) stock is rising higher on Wednesday following the release of positive results from a Phase II clinical trial.
It's time for another dive into the biggest pre-market stock movers as investors get ready to trade shares on Wednesday morning!